Our Team of Experts
Dr Chantal Lainesse
DVM, MSc, PhD, Dipl. ACVCP​
​
​Founder and CEO
Veterinary Clinical Pharmacologist
Dr Chantal Lainesse is a distinguished veterinary clinical pharmacologist with over 17 years of experience in the field. She holds a Doctor of Veterinary Medicine (DVM) from the Western College of Veterinary Medicine, obtained in 1995, and further advanced her education with a Master's in Veterinary Sciences (Pharmacology) and a PhD in Pharmacology from the Université de Montréal, completing her doctoral studies in 2007.
As a diplomate of the American College of Veterinary Clinical Pharmacology (ACVCP), Dr Lainesse has made significant contributions to veterinary medicine through her roles in research and development, regulatory affairs, and quality assurance. She is the founder and CEO of IntegRxal Consulting Strategies, Inc., where she provides specialized consulting services in pre-clinical and clinical drug development, and regulatory matters.
Dr. Lainesse's expertise extends to various aspects of veterinary clinical pharmacology, toxicology and business management, which she leverages to enhance the efficiency and competitiveness of organizations within the veterinary drug industry. Her work has been instrumental in advancing animal health and welfare through innovative solutions. In addition to her professional roles, Dr. Lainesse is fluent in both English and French, allowing her to engage with a diverse range of stakeholders in the veterinary field.
Her commitment to advancing veterinary science continues to influence practices within the industry, making her a respected leader among her peers.
Megan Miller
​​​
Executive Administrator
Project Manager
Regulatory Affairs
Megan Miller is a skilled project manager specializing in regulatory affairs at IntegRxal Consulting Strategies, Inc. With a strong background in project management and compliance, she plays a pivotal role in assisting clients navigate the intricate landscape of regulatory requirements for veterinary drug approvals.
At IntegRxal, Megan oversees a variety of projects related to regulatory submissions, ensuring that all processes comply with industry standards and regulations. She works collaboratively with cross-functional teams to devise strategies that optimize project outcomes while adhering to relevant laws and guidelines. Currently, she is pursuing a Bachelor of Science in Commerce, majoring in Business Management, which complements her expertise with creative insights in marketing.
Megan is recognized for her strong communication skills and her ability to cultivate collaborative relationships with clients and stakeholders. Her diverse background allows her to tackle challenges with a strategic approach, ensuring successful project delivery in both English and French.
Her commitment to excellence and continuous improvement makes her an invaluable member of the IntegRxal team. With a readiness to take on multiple responsibilities, she embraces challenges with enthusiasm and determination.
Dr Emmanuelle Verrette
DVM
​
Regulatory and Scientific Expert Advisor
Dr. Emmanuelle Verrette is a veterinarian known for her expertise in regulatory affairs, particularly during her 20-year tenure at the Veterinary Drugs Directorate (VDD) of Health Canada. She is a respected Regulatory and Scientific Expert Advisor at Integral Consulting Strategies, Inc., where she specializes in veterinary medicine and animal health.
As a licensed veterinarian, Dr Verrette combines her clinical expertise with extensive knowledge of regulatory affairs, ensuring that veterinary products meet rigorous standards for safety and efficacy.
​
In her role at Integral Consulting Strategies Inc., Dr Verrette collaborates with pharmaceutical companies to provide strategic guidance on product development, registration, and post-market surveillance. Her comprehensive understanding of the veterinary landscape allows her to help clients navigate the complexities of regulatory requirements effectively.
​
Beyond her advisory role, Dr Verrette is passionate about advancing the field of veterinary medicine. She actively participates in industry organizations and contributes to discussions on veterinary regulations, animal health, and best practices, contributing to shape the regulatory landscape for veterinary drugs in Canada.
​
Her unique combination of veterinary practice and regulatory knowledge positions her as a trusted advisor in the veterinary community (in French and in English), helping organizations bring innovative solutions to market while ensuring the highest standards of animal health and welfare.
​
Her work continues to influence policies and practices within the industry, making her a respected figure among her peers in veterinary pharmacology and regulatory affairs.